KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Short term Debt (2018 - 2024)

BioNTech SE's Short term Debt history spans 7 years, with the latest figure at $1.5 billion for Q4 2024.

  • For Q4 2024, Short term Debt rose 245.27% year-over-year to $1.5 billion; the TTM value through Dec 2024 reached $1.5 billion, up 245.27%, while the annual FY2024 figure was $1.6 billion, 247.84% up from the prior year.
  • Short term Debt for Q4 2024 was $1.5 billion at BioNTech SE, up from $446.7 million in the prior quarter.
  • Across five years, Short term Debt topped out at $1.7 billion in Q4 2021 and bottomed at $10.8 million in Q4 2020.
  • The 5-year median for Short term Debt is $801.0 million (2022), against an average of $898.9 million.
  • The largest annual shift saw Short term Debt surged 15507.79% in 2021 before it plummeted 52.7% in 2022.
  • A 5-year view of Short term Debt shows it stood at $10.8 million in 2020, then soared by 15507.79% to $1.7 billion in 2021, then plummeted by 52.7% to $801.0 million in 2022, then tumbled by 44.23% to $446.7 million in 2023, then skyrocketed by 245.27% to $1.5 billion in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Short term Debt are $1.5 billion (Q4 2024), $446.7 million (Q4 2023), and $801.0 million (Q4 2022).